Zoetis (ZTS) Cash from Investing Activities (2012 - 2026)

Zoetis (ZTS) reported Cash from Investing Activities of -$87.0 million for Q1 2026, up 57.14% year-over-year from -$55.4 million in Q1 2025, and up 47.59% quarter-over-quarter from -$166.0 million in Q4 2025.

Zoetis (ZTS) Cash from Investing Activities (2012 - 2026) Analysis & Trends

Zoetis (ZTS) has 15 years of Cash from Investing Activities data on file, last reported at -$87.0 million in Q1 2026.

  • Cash from Investing Activities for Q1 2026 came in at -$87.0 million, up 57.14% year-over-year; the trailing twelve-month figure through Mar 2026 was -$632.0 million (down 63.31% YoY), and the FY2025 annual result was -$748.0 million, down 137.46% from the prior year.
  • Cash from Investing Activities rose to -$87.0 million in Q1 2026 per ZTS's latest filing, from -$166.0 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $126.0 million in Q4 2024 and troughed at -$438.0 million in Q4 2022.
  • A 5-year average of -$165.3 million and a median of -$166.0 million in 2025 frame the typical range for Cash from Investing Activities.
  • The sharpest annual moves came in 2024 and 2025: Cash from Investing Activities soared 160.0% in 2024, then sank 231.75% in 2025.
  • A 5-year view of Cash from Investing Activities shows it stood at -$438.0 million in 2022, then surged by 52.05% to -$210.0 million in 2023, then soared by 160.0% to $126.0 million in 2024, then slumped by 231.75% to -$166.0 million in 2025, then jumped by 47.59% to -$87.0 million in 2026.
  • Business Quant data shows ZTS's Cash from Investing Activities at -$87.0 million in Q1 2026, -$166.0 million in Q4 2025, and -$160.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn 229.00 Mn
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn -87.00 Mn
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn 743.70 Mn
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn -506.20 Mn
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn -60.00 Mn
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn -2.08 Bn
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn 25.99 Mn
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn -15.45 Mn
10 Liquidia 5.74 Bn 5.52 Bn 121.79 Mn -2.83 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -87.00 Mn
Mar 31, 2026 -87.00 Mn
Dec 31, 2025 -166.00 Mn
Dec 31, 2025 -166.00 Mn
Sep 30, 2025 -160.00 Mn
Sep 30, 2025 -160.00 Mn
Jun 30, 2025 -219.00 Mn
Jun 30, 2025 -219.00 Mn
Mar 31, 2025 -203.00 Mn
Mar 31, 2025 -203.00 Mn
Dec 31, 2024 126.00 Mn
Dec 31, 2024 126.00 Mn
Sep 30, 2024 -178.00 Mn
Sep 30, 2024 -178.00 Mn
Jun 30, 2024 -132.00 Mn
Jun 30, 2024 -132.00 Mn
Mar 31, 2024 -131.00 Mn
Mar 31, 2024 -131.00 Mn
Dec 31, 2023 -210.00 Mn
Dec 31, 2023 -210.00 Mn